Organization | Our Lady of the Lake Regional Medical Center

Our Lady of the Lake Regional Medical Center Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial

2018

NCT03333408

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Our Lady of the Lake Hospital | Our Lady of the Lake Regional Medical Center

Active Ingredients

Drugs in Phase 4 Trials (5)

amiodarone (cordarone) (1 trial)

amoxicillin (1 trial)

clavulanate (Augmentin) (1 trial)

clindamycin (cleocin) (1 trial)

metformin (glucophage) (1 trial)

Drugs in Phase 1 Trials (2)

phenol (1 trial)

tetracaine (pontocaine) (1 trial)

Drugs in Other Trials (6)

bupivacaine (Exparel) (1 trial)

fluorouracil (efudex) (1 trial)

isoflurane (forane) (1 trial)

lidocaine (xylocaine) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Atrial Fibrillation (Phase 4)

Respiratory Insufficiency (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 13